Genelux (GNLX) Selling, General & Administrative (2022 - 2026)
Powered by 
Analysis
Genelux (GNLX) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | 3.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.39 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 4.11 Mn |
| Dec 31, 2023 | 2.84 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 694,000.00 |
| Sep 30, 2022 | 2.24 Mn |